News Conference News ADA 2023 Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1 Shelley Wood June 29, 2023
News Conference News ADA 2023 Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention Michael O'Riordan June 28, 2023
News Daily News AHA Scientific Statement Addresses Health Disparities in PAD L.A. McKeown June 23, 2023
News Conference News LINC 2023 What Works, What’s Noise? Novel Approaches Offer Hope in CLTI L.A. McKeown June 07, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News Think Differently: Diabetes, CVD Risks in Asian Americans Not Uniform, AHA Says Caitlin E. Cox May 09, 2023
News Daily News Sugary Drinks Up CVD and All-Cause Mortality Risks in Type 2 Diabetes Michael O'Riordan May 01, 2023
News Daily News New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF L.A. McKeown April 19, 2023
News Daily News CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors Yael L. Maxwell April 13, 2023
News Daily News To Improve CV Care in US South Asians, Understand Unique ASCVD Risks: ACC Yael L. Maxwell April 12, 2023
News Daily News Inactivity Pandemic Poised to Undo CVD Prevention Advances Michael O'Riordan April 11, 2023
News Daily News Regaining Weight Won’t Erode CV Risk Factor Benefits Short Term L.A. McKeown March 31, 2023
News Conference News ACC 2023 Diabetic Patients in Middle East, Africa Overburdened by ASCVD Michael O'Riordan March 14, 2023